CONTRIBUTION OF LOW-MOLECULAR WEIGHT HEPARIN ADDITION TO CONCOMITANT CHEMORADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOME MULTIFORME

Zincircioglu, S. B.Kaplan, M. A.Isikdogan, A.Cil, T.Kucukoner, M.Karadayi, B.Dirier, A.2024-04-242024-04-2420100923-7534https://hdl.handle.net/11468/2160435th European-Society-for-Medical-Oncology (ESMO) Congress -- OCT 08-12, 2010 -- Milan, ITALY[Abstract Not Available]eninfo:eu-repo/semantics/closedAccess[No Keyword]CONTRIBUTION OF LOW-MOLECULAR WEIGHT HEPARIN ADDITION TO CONCOMITANT CHEMORADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOME MULTIFORMECONTRIBUTION OF LOW-MOLECULAR WEIGHT HEPARIN ADDITION TO CONCOMITANT CHEMORADIOTHERAPY IN THE TREATMENT OF GLIOBLASTOME MULTIFORMEConference Object21331331WOS:000284592300265Q1